Nicholas Wareham

Has grant

Director

University of Cambridge
Country flagUnited Kingdom

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Developing and disseminating tools for population health improvement: an online interactive atlas for identifying environmental change

Open Date: 2022-01-01

Close Date: 2023-12-31

Grant: Close

Prospective associations of major depressive disorder with atherosclerotic cardiovascular disease, cognitive impairment and mortality in the community

Open Date: 2022-01-01

Close Date: 2025-12-31

Grant: Close

The EPIC-Norfolk Study

Open Date: 2021-12-15

Close Date: 2022-03-30

Grant: Close

Investigating shared molecular pathways underlying cardiovascular diseases, diabetes and cancer

Open Date: 2020-06-30

Close Date: 2020-12-31

Grant: Close

Aetiology and Mechanisms of Diabetes and Related Metabolic Disorders of Later Life

Open Date: 2020-03-31

Close Date: 2025-03-30

Articles (25)

Background Previous studies on the reproducibility of 7-day accelerometer measurements have been limited by small sample sizes and short follow-up periods. We aimed to assess the long-term reproducibility of accelerometer-derived physical activity and sleep, and to illustrate the impact of regression dilution bias on the association between daily step count and coronary heart disease (CHD) in UK Biobank. Methods We analysed data from 3138 UK Biobank participants in the main accelerometry sub-study with up to four repeat accelerometer measurements after 3–4 years. Nine physical activity and sleep phenotypes were extracted to capture different movement behaviours. Reproducibility was assessed by using intraclass correlation coefficients (ICCs). The impact on disease associations was illustrated by considering daily step count and incident CHD using Cox regression (87 038 participants; 3879 CHD events), before and after correction for regression dilution. Results Among the 3138 participants, 51% were women and the mean (SD) age was 63.1 (9.4) years. Reproducibility was good for overall activity, with an ICC (95% confidence interval) of 0.75 (0.74–0.76), and moderate for other phenotypes, with ICCs ranging from 0.58 (0.56–0.59) for sleep efficiency to 0.69 (0.68–0.70) for sedentary behaviour. In our example, the inverse association between daily step count and CHD showed a 20% lower risk of CHD per usual 4000 steps after correcting for regression dilution compared with 13% before correction. Conclusion Accelerometer measurements are moderately reproducible and comparable to measures such as blood pressure. Correction for regression dilution bias is crucial to quantify associations of usual physical activity and sleep with disease risk.

Year:

2026

Aims Both plasma levels of remnant cholesterol and low-density lipoprotein (LDL) cholesterol levels are independent risk factors for atherosclerotic cardiovascular disease. However, only remnant cholesterol has consistently been associated with systemic inflammation. In this study, we aimed to assess the extent to which inflammation mediates the effect of remnant and LDL cholesterol on (non)fatal major adverse cardiovascular events (MACE), comprising of coronary artery disease and ischaemic stroke. Methods and results This prospective study included 16,445 participants without prior atherosclerotic cardiovascular disease from the EPIC-Norfolk study, with a mean age of 58.8 ± 9.1 years, of which 9,357 (56.9%) were women. Every 1 mmol/L higher remnant cholesterol was associated with 29.5% higher high-sensitivity C-reactive protein (hsCRP) levels [95% Confidence Interval (CI): 22.1, 37.4, P < 0.001], whereas LDL cholesterol was not significantly associated with hsCRP levels in the fully adjusted model. Additionally, each 1 mmol/L higher remnant cholesterol was associated with a hazard ratio (HR) of 1.31 (95% CI: 1.14, 1.50, P < 0.001) for MACE, compared with an HR of 1.21 (95% CI: 1.13, 1.31, P < 0.001) for LDL cholesterol. Mediation analysis showed that hsCRP mediated 5.9% (95% CI: 1.2, 10.6%, P < 0.001) of the effect of remnant cholesterol on MACE, whereas hsCRP did not mediate the effect of LDL cholesterol. Conclusion Plasma remnant cholesterol levels are independently associated with systemic inflammation and cardiovascular events. Inflammation, as measured with hsCRP, contributed minorly to the association between remnant cholesterol and MACE. This underscores the need to address both remnant cholesterol and systemic inflammation separately in the clinical management of cardiovascular disease. Lay summary This study finds that systemic inflammation does not influence the effect remnant cholesterol has on cardiovascular disease risk, suggesting the importance of addressing both remnant cholesterol and inflammation to manage cardiovascular health.

Year:

2026

Context Testosterone supplementation is increasingly widespread and has well-established beneficial effects on sexual function and metabolic health. However, there remains uncertainty regarding associated cardiovascular risks. Objective Human genetics studies demonstrated that Mendelian randomization approaches recapitulate the beneficial effects of testosterone therapy; here we apply this to cardiovascular disease. Design We performed a Mendelian randomization study to assess the causal effect of higher circulating testosterone on coronary artery disease (CAD). We also tested the phenotypic association between measured circulating testosterone and CAD in the cohort of men aged 40 to 69. Patients or Other Participants Testosterone genetic instrument data were derived from 425 097 European ancestry adults from the UK Biobank study and CAD from single nucleotide polymorphism-level summary statistics from 1 165 690 individuals in CARDIoGRAMplusC4D. Main Outcome Measure(s) CAD as defined in CARDIoGRAMplusC4D was the main outcome. In longitudinal analyses, CAD was defined according to medical records and self-report. Results We found that higher genetically predicted circulating testosterone conferred a higher risk of CAD in men [odds ratio (OR): 1.17, 95% confidence interval (CI) 1.07-1.27, P = 3.32 × 10−4]. There was no evidence of an effect in women (OR: 1.01, 95% CI 0.94-1.10, P = .73). The genetic association in men appeared to be mediated by higher blood pressure. In longitudinal observational analyses, a directionally opposite association was observed in men, likely arising due to confounding by type 2 diabetes and body mass index. Conclusion These data suggest that increased testosterone may increase the risk of cardiovascular disease and that this safety concern should be a focus in future clinical trials for testosterone supplementation.

Year:

2026

Mechanisms underlying sex differences in the development and prognosis of many diseases remain largely elusive. Here, we systematically investigated sex differences in the genetic regulation of plasma proteome (>5800 protein targets) across two cohorts (30,307 females; 26,058 males). Plasma levels of two-thirds of protein targets differ significantly by sex. In contrast, genetic effects on protein targets are remarkably similar across sexes, with only 103 sex-differential protein quantitative loci (sd-pQTLs; for 2.9% and 0.3% of protein targets from antibody- and aptamer-based platforms, respectively). A third of those show evidence of sexual discordance, i.e., effects observed in one sex only ( n = 30) or opposite effect directions ( n = 1 for CDH15). Phenome-wide analyses of 365 outcomes in UK Biobank did not provide evidence that the identified sd-pQTLs accounted for sex-differential disease risk. Our results demonstrate similarities in the genetic regulation of protein levels by sex with important implications for genetically-guided drug target discovery and validation.

Year:

2025

Comparisons of cardiorespiratory fitness across population studies are hindered by a lack of standardisation in exercise testing and reliance on estimation methods that assume steady-state exercise. We developed a generalised framework that standardises maximal oxygen consumption estimation by harmonising dynamic heart rate modelling with individualised calibration of exercise energetics. We constructed and evaluated the framework using submaximal and maximal tests (treadmill walking and running, cycle ergometer, stepping, overground walking) from 911 adults. Agreement between framework estimates and directly measured was strong (non-significant bias, Pearson’s r=0.80). We then applied both framework and canonical methods to estimate in 11,307 UK Fenland Study adults and examined associations with cardiometabolic risk. Framework-estimated was more strongly associated with blood glucose, fasting insulin, and high-density lipoprotein cholesterol (combined risk factor model AIC=125,743) compared to canonical estimates (AIC=129,227). The framework standardises fitness estimation across diverse tests, yielding a more reliable and comparable biomarker of cardiometabolic health.

Year:

2025

Introduction : Estimating free-living physical activity (PA) with continuous heart rate (HR) monitoring is challenging due to individual variation in the relationship between HR and energy expenditure. This variation can be captured through individual calibration with graded exercise tests, but structured tests with prescribed load require medical screening and are not always feasible in population settings. We present and evaluate an individual calibration method using HR response to a less demanding self-paced walk test. Methods : Six hundred and forty-three participants from the Fenland Study (Cambridgeshire, the United Kingdom) completed a 200-m self-paced walk test, a treadmill test, and 1 week of continuous HR and accelerometry monitoring. Mixed-effects regression was used to derive a walk test calibration model from HR response to the walk using treadmill-based parameters as criterion. Free-living PA estimates from the calibration model were compared with treadmill-calibrated and non-exercise-calibrated estimates. Results : Walk calibration captured 57% of the variance in the HR–energy expenditure relationship determined by the treadmill test. Applying walk calibration to data from free-living yielded similar PA estimates to those using treadmill calibration (52.7 vs. 52.0 kJ·kg −1 ·day −1 ; mean difference: 0.7 kJ·kg −1 ·day −1 , 95% confidence interval [−0.0, 1.5]) and high correlation ( r = .89). Individual differences were observed (root mean square error: 10.0 kJ·kg −1 ·day −1 ; 95% limits of agreement: −20.6, 19.1 kJ·kg −1 ·day −1 ). Walk calibration improved precision by 29% compared with nonexercise group calibration (root mean square error: 14.0 kJ·kg −1 ·day −1 ; 95% limits of agreement: −30.4, 24.5 kJ·kg −1 ·day −1 ). Conclusions : A 200-m self-paced walk test captures between-individual variation in the HR–energy expenditure relationship and facilitates estimation of free-living PA in population settings.

Year:

2024

Year:

2024

Childhood-onset type 1 diabetes (T1D) is associated with substantial psychiatric morbidity in later life, but it remains unknown whether these associations are due to common underlying biological mechanisms or the impacts of living with the condition and its treatment. Here, using Czech national register data, we identified children with T1D aged ≤14 years between 1994 and 2007 and estimated the risk of psychiatric disorders up to 24 years later. We found that children diagnosed with T1D had an elevated risk of developing substance use, mood, anxiety and personality disorders, and behavioral syndromes. Conversely, we found that children with T1D had a lower risk of developing psychotic disorders. In Mendelian randomization analysis, we found an association with schizophrenia, which, however, did not persist following multiple testing adjustment. The combined observational and Mendelian randomization evidence suggests that T1D diagnosis in childhood predisposes to far-reaching, extensive psychiatric morbidity, which is unlikely to be explicable by common underlying biological mechanisms. The findings of this study highlight that monitoring and addressing the mental health needs of children with T1D is imperative, whereas glucose dysregulation and/or inflammation implicated in schizophrenia pathogenesis warrants future research.

Year:

2024

Broad-capture proteomic platforms now enable simultaneous assessment of thousands of plasma proteins, but most of these are not actively secreted and their origins are largely unknown. Here we integrate genomic with deep phenomic information to identify modifiable and non-modifiable factors associated with 4,775 plasma proteins in ~8,000 mostly healthy individuals. We create a data-driven map of biological influences on the human plasma proteome and demonstrate segregation of proteins into clusters based on major explanatory factors. For over a third ( N = 1,575) of protein targets, joint genetic and non-genetic factors explain 10–77% of the variation in plasma (median 19.88%, interquartile range 14.01–31.09%), independent of technical factors (median 2.48%, interquartile range 0.78–6.41%). Together with genetically anchored causal inference methods, our map highlights potential causal associations between modifiable risk factors and plasma proteins for hundreds of protein–disease associations, for example, COL6A3, which possibly mediates the association between reduced kidney function and cardiovascular disease. We provide a map of biological and technical influences on the human plasma proteome to help contextualize findings from proteomic studies.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (96)

Xiaofeng Zhu

Professor

Case Western Reserve University

UNITED STATES
View details

Harold Snieder

Scientific Staff

University Medical Center Groningen

NETHERLANDS
View details

Amy Bentley

National Human Genome Research Institute

UNITED STATES
View details

Cristina Menni

King’s College London

UNITED KINGDOM
View details

Marcela Guevara

Instituto de Salud Pública de Navarra

SPAIN
View details

Kathryn Martin

Senior Lecturer

University of Aberdeen

UNITED KINGDOM
View details

Ben Lacey

-

UNITED KINGDOM
View details

Nita G Forouhi

Programme Leader, MRC Investigator

University of Cambridge School of Clinical Medicine

UNITED KINGDOM
View details

Brenda WJH Penninx

Professor

-

NETHERLANDS
View details

Joseph McCormick

James H. Steele Professor

-

UNITED STATES
View details

Renata L Riha

Honorary Reader (Associate Professor)

University of Edinburgh

UNITED KINGDOM
View details

Daniel Prieto-Alhambra

Professor (part-time)

Erasmus MC

NETHERLANDS
View details

Dana Dawson

Professor

University of Aberdeen

UNITED KINGDOM
View details

Yunhe Wang

University of Oxford

UNITED KINGDOM
View details

Anne Tjonneland

Professor

Københavns Universitet

DENMARK
View details

Seunggeun Lee

Professor

Seoul National University

SOUTH KOREA
View details

Matthijs Boekholdt

University of Amsterdam

NETHERLANDS
View details

Harry Hemingway

University College London

UNITED KINGDOM
View details

Vilmundur Gudnason

Professor

University of Iceland

ICELAND
View details

Ayush Giri

Assistant Professor

Vanderbilt University Medical Center

UNITED STATES
View details

Simon R. Cox

Personal Chair of Brain and Cognitive Ageing

University of Edinburgh

UNITED KINGDOM
View details

Serena Sanna

Scientific Staff

University Medical Center Groningen

NETHERLANDS
View details

Jean Adams

Programme leader and Professor

University of Cambridge

UNITED KINGDOM
View details

Clint Miller

Associate Professor

Stanford University

UNITED STATES
View details

Jennifer Ann Smith

Professor

University of Michigan

UNITED STATES
View details

Sarah Lewington

University of Oxford

UNITED KINGDOM
View details

Sarah Harris

University of Edinburgh

UNITED KINGDOM
View details

Adam Butterworth

Professor of Molecular Epidemiology

University of Cambridge

UNITED KINGDOM
View details

Patricia Munroe

Professor of Molecular Medicine

Queen Mary University of London

UNITED KINGDOM
View details

Ching-Ti Liu

Boston University

UNITED STATES
View details

Erik S G Stroes

Amsterdam University Medical Centers

NETHERLANDS
View details

Ko Willems van Dijk

Professor

Leiden University Medical Center

NETHERLANDS
View details

Tomas Gonzales

University of Cambridge

UNITED KINGDOM
View details

Timo Lakka

Professor of Medical Physiology

University of Eastern Finland

FINLAND
View details

massimo mangino

Honorary Senior Lecturer

King’s College London

UNITED KINGDOM
View details

Heming Wang

Assistant Professor

Brigham and Women's Hospital

UNITED STATES
View details

Ilja Nolte

Senior Researcher of Statistical Genetics and Genetic Epidemiology

University Medical Center Groningen

NETHERLANDS
View details

Saima Afaq

Lecturer

University of York

UNITED KINGDOM
View details

Courtney Davis

University of South Australia

AUSTRALIA
View details

Heather M Highland

University of North Carolina at Chapel Hill

UNITED STATES
View details

Marcus Dörr

University Medicine Greifswald

GERMANY
View details

Paul de Vries

Assistant Professor

The University of Texas Health Science Center at Houston School of Public Health

UNITED STATES
View details

Lisa de las Fuentes

Professor of Medicine and Biostatistics

Washington University School of Medicine

UNITED STATES
View details

Maik Pietzner

Professor

Queen Mary University of London

UNITED KINGDOM
View details

Hannah Taylor

University of Oxford

UNITED KINGDOM
View details

Chloe Orkin

Dean for Healthcare Transformation

Queen Mary University of London

UNITED KINGDOM
View details

Reedik Mägi

Professor of Bioinformatics

University of Tartu

ESTONIA
View details

Albert Prats Uribe

University of Oxford

UNITED KINGDOM
View details

Junqing Xie

University of Oxford

UNITED KINGDOM
View details

Iris M. Heid

University of Regensburg

GERMANY
View details

Rodney Scott

Prof. of Medical Genetics

University of Newcastle Australia

AUSTRALIA
View details

Myriam Fornage

-

UNITED STATES
View details

Changwei Li

Associate Professor

University of Texas Southwestern Medical Center

UNITED STATES
View details

Mary Feitosa

Associate Professor

Washington University School of Medicine

UNITED STATES
View details

Debbie A Lawlor

Academic , Professor of Epidemiology, MRC Investigator and BHF Chair

University of Bristol

UNITED KINGDOM
View details

Sami Heikkinen

Research Director

University of Eastern Finland

FINLAND
View details

Lorenz Risch

Titularprofessur für das Fach klinische Biochemie

University of Bern

SWITZERLAND
View details

Peter Y Liu

University of California

UNITED STATES
View details

Tanika Kelly

Professor

University of Chicago

UNITED STATES
View details

Nora Franceschini

Professor

University of North Carolina

UNITED STATES
View details

Kari North

Professor

University of North Carolina at Chapel Hill

UNITED STATES
View details

Jody Hoenink

Research Associate

University of Cambridge

UNITED KINGDOM
View details

Phyo K. Myint

University of Aberdeen

UNITED KINGDOM
View details

Kisung Nam

Seoul National University

SOUTH KOREA
View details

Nick S Nurmohamed

University of Amsterdam

NETHERLANDS
View details

Jonathan Hodgson

Professor of Nutrition and Epidemiology

Edith Cowan University

AUSTRALIA
View details

Olli T. Raitakari

University of Turku

FINLAND
View details

Amy L. Ahern

Research Professor

University of Cambridge

UNITED KINGDOM
View details

Michael Province

Professor, Head Division of Statistical Genomics

Washington University in St. Louis

UNITED STATES
View details

Esther Molina-Montes

Universidad de Granada

SPAIN
View details

Uwe Völker

Professor, Head of Department

Universitätsmedizin Greifswald

GERMANY
View details

Quan Sun

Research Assistant Professor

University of Pennsylvania

UNITED STATES
View details

John Attia

University of Newcastle Australia

AUSTRALIA
View details

Patrik Rorsman

Professor

University of Oxford

UNITED KINGDOM
View details

Nicholette Allred

Wake Forest Baptist Medical Center

UNITED STATES
View details

Sébastien Thériault

Associate Professor

Laval University

CANADA
View details

W. James Gauderman

professor

University of Southern California

UNITED STATES
View details

Mariaelisa Graff

Assistant Professor

University of North Carolina

UNITED STATES
View details

Brian Cade

Investigator

Brigham and Women's Hospital

UNITED STATES
View details

Steven B. Heymsfield

Pennington Biomedical Research Center

UNITED STATES
View details

G. Kees Hovingh

University of Amsterdam

NETHERLANDS
View details

Terho Lehtimäki

University of Tampere

FINLAND
View details

Laurens F. Reeskamp

University of Amsterdam

NETHERLANDS
View details

SINA A. GHARIB

University of Washington

UNITED STATES
View details

Jeffrey Kroon

Assistant Professor, Staff

Amsterdam UMC Locatie AMC

NETHERLANDS
View details

Kenneth Westerman

Assistant Investigator

Massachusetts General Hospital

UNITED STATES
View details

Jian'an Luan

University of Cambridge

UNITED KINGDOM
View details

Hugues Aschard

Head of Statical Genetics unit

Institut Pasteur

FRANCE
View details

Raymond Noordam

Assistant Professor

Leiden University Medical Center

NETHERLANDS
View details

Jemma Hopewell

Professor of Precision Medicine & Epidemiology

University of Oxford

UNITED KINGDOM
View details

Victoria Keevil

Senior Clinical Lecturer and NIHR Exeter BRC Mid-Career Fellow

University of Exeter

UNITED KINGDOM
View details

Tammy Tong

University of Oxford

UNITED KINGDOM
View details

Valborg Gudmundsdottir

Research Assistant Professor

University of Iceland

ICELAND
View details

Søren Brage

University of Cambridge

UNITED KINGDOM
View details

Danni Chen

Aarhus University

DENMARK
View details

Aldo Grefhorst

-

NETHERLANDS
View details